Meghmani Organics Limited
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, betacyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinot… Read more
Meghmani Organics Limited (MOL) - Net Assets
Latest net assets as of September 2025: ₹15.40 Billion INR
Based on the latest financial reports, Meghmani Organics Limited (MOL) has net assets worth ₹15.40 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹32.85 Billion) and total liabilities (₹17.45 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹15.40 Billion |
| % of Total Assets | 46.87% |
| Annual Growth Rate | 8.01% |
| 5-Year Change | 29.17% |
| 10-Year Change | N/A |
| Growth Volatility | 180.76 |
Meghmani Organics Limited - Net Assets Trend (2015–2024)
This chart illustrates how Meghmani Organics Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Meghmani Organics Limited (2015–2024)
The table below shows the annual net assets of Meghmani Organics Limited from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₹15.15 Billion | -0.81% |
| 2023-12-31 | ₹15.28 Billion | -8.48% |
| 2022-12-31 | ₹16.69 Billion | +13.85% |
| 2021-12-31 | ₹14.66 Billion | +24.99% |
| 2020-12-31 | ₹11.73 Billion | -16.11% |
| 2019-12-31 | ₹13.98 Billion | +21.30% |
| 2018-12-31 | ₹11.53 Billion | +563.34% |
| 2017-12-31 | ₹1.74 Billion | +13.83% |
| 2016-12-31 | ₹1.53 Billion | -79.85% |
| 2015-12-31 | ₹7.58 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Meghmani Organics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1257087800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹12.57 Billion | 82.96% |
| Common Stock | ₹254.31 Million | 1.68% |
| Other Comprehensive Income | ₹762.34 Million | 5.03% |
| Other Components | ₹1.57 Billion | 10.33% |
| Total Equity | ₹15.15 Billion | 100.00% |
Meghmani Organics Limited Competitors by Market Cap
The table below lists competitors of Meghmani Organics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Taiwan Kong King Co Ltd
TWO:3093
|
$64.34 Million |
|
Dallasnews Corp
NASDAQ:DALN
|
$64.35 Million |
|
Digia Oyj
HE:DIGIA
|
$64.36 Million |
|
Hafnia Limited
NYSE:HAFN
|
$64.37 Million |
|
FLITTO Inc
KQ:300080
|
$64.29 Million |
|
Arizon RFID Tech (Cayman) Co
TW:6863
|
$64.28 Million |
|
Viva Wine Group AB
ST:VIVA
|
$64.27 Million |
|
AADI BIOSCIENCES DL-0001
F:3350
|
$64.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Meghmani Organics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 15,276,909,000 to 15,152,575,000, a change of -124,334,000 (-0.8%).
- Net loss of 106,008,000 reduced equity.
- Dividend payments of 99,687,000 reduced retained earnings.
- Other comprehensive income decreased equity by 29,469,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹-106.01 Million | -0.7% |
| Dividends Paid | ₹99.69 Million | -0.66% |
| Other Comprehensive Income | ₹-29.47 Million | -0.19% |
| Other Changes | ₹110.83 Million | +0.73% |
| Total Change | ₹- | -0.81% |
Book Value vs Market Value Analysis
This analysis compares Meghmani Organics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.75x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.81x to 0.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | ₹24.79 | ₹44.93 | x |
| 2016-12-31 | ₹6.00 | ₹44.93 | x |
| 2017-12-31 | ₹6.83 | ₹44.93 | x |
| 2018-12-31 | ₹39.52 | ₹44.93 | x |
| 2019-12-31 | ₹47.61 | ₹44.93 | x |
| 2020-12-31 | ₹46.13 | ₹44.93 | x |
| 2021-12-31 | ₹57.65 | ₹44.93 | x |
| 2022-12-31 | ₹65.64 | ₹44.93 | x |
| 2023-12-31 | ₹60.07 | ₹44.93 | x |
| 2024-12-31 | ₹60.03 | ₹44.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Meghmani Organics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.70%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.50%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 2.04x
- Recent ROE (-0.70%) is below the historical average (25.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 13.07% | 6.19% | 0.84x | 2.52x | ₹193.79 Million |
| 2016 | 57.45% | 6.16% | 5.78x | 1.61x | ₹724.37 Million |
| 2017 | 98.58% | 9.50% | 5.75x | 1.80x | ₹1.54 Billion |
| 2018 | 25.04% | 12.24% | 0.86x | 2.37x | ₹1.51 Billion |
| 2019 | 19.86% | 11.14% | 0.79x | 2.26x | ₹1.19 Billion |
| 2020 | 15.90% | 11.57% | 0.82x | 1.68x | ₹691.73 Million |
| 2021 | 20.76% | 12.31% | 0.88x | 1.91x | ₹1.58 Billion |
| 2022 | 14.24% | 9.40% | 0.79x | 1.92x | ₹707.85 Million |
| 2023 | -6.94% | -6.85% | 0.51x | 1.99x | ₹-2.59 Billion |
| 2024 | -0.70% | -0.50% | 0.69x | 2.04x | ₹-1.62 Billion |
Industry Comparison
This section compares Meghmani Organics Limited's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $1,982,728,463
- Average return on equity (ROE) among peers: 6.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Meghmani Organics Limited (MOL) | ₹15.40 Billion | 13.07% | 1.13x | $64.32 Million |
| Agro Phos India Limited (AGROPHOS) | $204.99 Million | 49.16% | 1.55x | $4.25 Million |
| Aries Agro Limited (ARIES) | $2.09 Billion | 5.01% | 1.28x | $32.15 Million |
| Astec LifeSciences Limited (ASTEC) | $325.25 Million | 31.90% | 2.00x | $35.96 Million |
| Bayer Cropscience Limited (BAYERCROP) | $4.51 Billion | 20.95% | 1.08x | $984.38 Million |
| Best Agrolife Limited (BESTAGRO) | $31.27 Million | 2.19% | 4.68x | $20.62 Million |
| Bhagiradha Chemicals & Industries Limited (BHAGCHEM) | $3.13 Billion | 14.41% | 0.43x | $103.36 Million |
| Bharat Rasayan Limited (BHARATRAS) | $294.66 Million | 2.97% | 0.30x | $67.58 Million |
| Bohra Industries Limited (BOHRAIND) | $399.71 Million | -100.78% | 2.57x | $2.29 Million |
| Bombay Super Hybrid Seeds Limited (BSHSL) | $12.16 Million | 22.41% | 2.68x | $25.43 Million |
| Chambal Fertilizers & Chemicals Limited (CHAMBLFERT) | $8.83 Billion | 21.55% | 2.20x | $770.15 Million |